Global B Cell Maturation Antigen Targeted Therapy Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global B Cell Maturation Antigen Targeted Therapy Market Size 2017-2028

2.1.2 B Cell Maturation Antigen Targeted Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 B Cell Maturation Antigen Targeted Therapy Segment by Treatment Method

2.2.1 Antibody-Drug Conjugates

2.2.2 CAR-T Cells and Bispecific T Cell Engagers

2.3 B Cell Maturation Antigen Targeted Therapy Market Size by Treatment Method

2.3.1 B Cell Maturation Antigen Targeted Therapy Market Size CAGR by Treatment Method (2017 VS 2022 VS 2028)

2.3.2 Global B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Treatment Method (2017-2022)

2.4 B Cell Maturation Antigen Targeted Therapy Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Others

2.5 B Cell Maturation Antigen Targeted Therapy Market Size by Application

2.5.1 B Cell Maturation Antigen Targeted Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Application (2017-2022)

3 B Cell Maturation Antigen Targeted Therapy Market Size by Player

3.1 B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Players

3.1.1 Global B Cell Maturation Antigen Targeted Therapy Revenue by Players (2020-2022)

3.1.2 Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share by Players (2020-2022)

3.2 Global B Cell Maturation Antigen Targeted Therapy Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 B Cell Maturation Antigen Targeted Therapy by Regions

4.1 B Cell Maturation Antigen Targeted Therapy Market Size by Regions (2017-2022)

4.2 Americas B Cell Maturation Antigen Targeted Therapy Market Size Growth (2017-2022)

4.3 APAC B Cell Maturation Antigen Targeted Therapy Market Size Growth (2017-2022)

4.4 Europe B Cell Maturation Antigen Targeted Therapy Market Size Growth (2017-2022)

4.5 Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size Growth (2017-2022)

5 Americas

5.1 Americas B Cell Maturation Antigen Targeted Therapy Market Size by Country (2017-2022)

5.2 Americas B Cell Maturation Antigen Targeted Therapy Market Size by Treatment Method (2017-2022)

5.3 Americas B Cell Maturation Antigen Targeted Therapy Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC B Cell Maturation Antigen Targeted Therapy Market Size by Region (2017-2022)

6.2 APAC B Cell Maturation Antigen Targeted Therapy Market Size by Treatment Method (2017-2022)

6.3 APAC B Cell Maturation Antigen Targeted Therapy Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe B Cell Maturation Antigen Targeted Therapy by Country (2017-2022)

7.2 Europe B Cell Maturation Antigen Targeted Therapy Market Size by Treatment Method (2017-2022)

7.3 Europe B Cell Maturation Antigen Targeted Therapy Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa B Cell Maturation Antigen Targeted Therapy by Region (2017-2022)

8.2 Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size by Treatment Method (2017-2022)

8.3 Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global B Cell Maturation Antigen Targeted Therapy Market Forecast

10.1 Global B Cell Maturation Antigen Targeted Therapy Forecast by Regions (2023-2028)

10.1.1 Global B Cell Maturation Antigen Targeted Therapy Forecast by Regions (2023-2028)

10.1.2 Americas B Cell Maturation Antigen Targeted Therapy Forecast

10.1.3 APAC B Cell Maturation Antigen Targeted Therapy Forecast

10.1.4 Europe B Cell Maturation Antigen Targeted Therapy Forecast

10.1.5 Middle East & Africa B Cell Maturation Antigen Targeted Therapy Forecast

10.2 Americas B Cell Maturation Antigen Targeted Therapy Forecast by Country (2023-2028)

10.2.1 United States B Cell Maturation Antigen Targeted Therapy Market Forecast

10.2.2 Canada B Cell Maturation Antigen Targeted Therapy Market Forecast

10.2.3 Mexico B Cell Maturation Antigen Targeted Therapy Market Forecast

10.2.4 Brazil B Cell Maturation Antigen Targeted Therapy Market Forecast

10.3 APAC B Cell Maturation Antigen Targeted Therapy Forecast by Region (2023-2028)

10.3.1 China B Cell Maturation Antigen Targeted Therapy Market Forecast

10.3.2 Japan B Cell Maturation Antigen Targeted Therapy Market Forecast

10.3.3 Korea B Cell Maturation Antigen Targeted Therapy Market Forecast

10.3.4 Southeast Asia B Cell Maturation Antigen Targeted Therapy Market Forecast

10.3.5 India B Cell Maturation Antigen Targeted Therapy Market Forecast

10.3.6 Australia B Cell Maturation Antigen Targeted Therapy Market Forecast

10.4 Europe B Cell Maturation Antigen Targeted Therapy Forecast by Country (2023-2028)

10.4.1 Germany B Cell Maturation Antigen Targeted Therapy Market Forecast

10.4.2 France B Cell Maturation Antigen Targeted Therapy Market Forecast

10.4.3 UK B Cell Maturation Antigen Targeted Therapy Market Forecast

10.4.4 Italy B Cell Maturation Antigen Targeted Therapy Market Forecast

10.4.5 Russia B Cell Maturation Antigen Targeted Therapy Market Forecast

10.5 Middle East & Africa B Cell Maturation Antigen Targeted Therapy Forecast by Region (2023-2028)

10.5.1 Egypt B Cell Maturation Antigen Targeted Therapy Market Forecast

10.5.2 South Africa B Cell Maturation Antigen Targeted Therapy Market Forecast

10.5.3 Israel B Cell Maturation Antigen Targeted Therapy Market Forecast

10.5.4 Turkey B Cell Maturation Antigen Targeted Therapy Market Forecast

10.5.5 GCC Countries B Cell Maturation Antigen Targeted Therapy Market Forecast

10.6 Global B Cell Maturation Antigen Targeted Therapy Forecast by Treatment Method (2023-2028)

10.7 Global B Cell Maturation Antigen Targeted Therapy Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Information

11.1.2 GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Product Offered

11.1.3 GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 GlaxoSmithKline Main Business Overview

11.1.5 GlaxoSmithKline Latest Developments

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Information

11.2.2 Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Product Offered

11.2.3 Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Johnson & Johnson Main Business Overview

11.2.5 Johnson & Johnson Latest Developments

11.3 Amgen

11.3.1 Amgen Company Information

11.3.2 Amgen B Cell Maturation Antigen Targeted Therapy Product Offered

11.3.3 Amgen B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Amgen Main Business Overview

11.3.5 Amgen Latest Developments

11.4 Seagen

11.4.1 Seagen Company Information

11.4.2 Seagen B Cell Maturation Antigen Targeted Therapy Product Offered

11.4.3 Seagen B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Seagen Main Business Overview

11.4.5 Seagen Latest Developments

11.5 AbbVie

11.5.1 AbbVie Company Information

11.5.2 AbbVie B Cell Maturation Antigen Targeted Therapy Product Offered

11.5.3 AbbVie B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 AbbVie Main Business Overview

11.5.5 AbbVie Latest Developments

11.6 Novartis

11.6.1 Novartis Company Information

11.6.2 Novartis B Cell Maturation Antigen Targeted Therapy Product Offered

11.6.3 Novartis B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Novartis Main Business Overview

11.6.5 Novartis Latest Developments

11.7 BioTherapeutics

11.7.1 BioTherapeutics Company Information

11.7.2 BioTherapeutics B Cell Maturation Antigen Targeted Therapy Product Offered

11.7.3 BioTherapeutics B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 BioTherapeutics Main Business Overview

11.7.5 BioTherapeutics Latest Developments

11.8 Celgene

11.8.1 Celgene Company Information

11.8.2 Celgene B Cell Maturation Antigen Targeted Therapy Product Offered

11.8.3 Celgene B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Celgene Main Business Overview

11.8.5 Celgene Latest Developments

11.9 Bluebird Bio

11.9.1 Bluebird Bio Company Information

11.9.2 Bluebird Bio B Cell Maturation Antigen Targeted Therapy Product Offered

11.9.3 Bluebird Bio B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Bluebird Bio Main Business Overview

11.9.5 Bluebird Bio Latest Developments

11.10 Bristol Mayer Squibb

11.10.1 Bristol Mayer Squibb Company Information

11.10.2 Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Product Offered

11.10.3 Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Bristol Mayer Squibb Main Business Overview

11.10.5 Bristol Mayer Squibb Latest Developments

11.11 Carsgen Therapeutics

11.11.1 Carsgen Therapeutics Company Information

11.11.2 Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offered

11.11.3 Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Carsgen Therapeutics Main Business Overview

11.11.5 Carsgen Therapeutics Latest Developments

11.12 Juno Therapeutics

11.12.1 Juno Therapeutics Company Information

11.12.2 Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offered

11.12.3 Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Juno Therapeutics Main Business Overview

11.12.5 Juno Therapeutics Latest Developments

11.13 Cogent Bioscience

11.13.1 Cogent Bioscience Company Information

11.13.2 Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Product Offered

11.13.3 Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Cogent Bioscience Main Business Overview

11.13.5 Cogent Bioscience Latest Developments

11.14 CRISPR Therapeutics

11.14.1 CRISPR Therapeutics Company Information

11.14.2 CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offered

11.14.3 CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 CRISPR Therapeutics Main Business Overview

11.14.5 CRISPR Therapeutics Latest Developments

11.15 Allogene Therapeutics

11.15.1 Allogene Therapeutics Company Information

11.15.2 Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offered

11.15.3 Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Allogene Therapeutics Main Business Overview

11.15.5 Allogene Therapeutics Latest Developments

11.16 Harpoon Therapeutics

11.16.1 Harpoon Therapeutics Company Information

11.16.2 Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offered

11.16.3 Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Harpoon Therapeutics Main Business Overview

11.16.5 Harpoon Therapeutics Latest Developments

11.17 Poseida Therapeutics

11.17.1 Poseida Therapeutics Company Information

11.17.2 Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offered

11.17.3 Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Poseida Therapeutics Main Business Overview

11.17.5 Poseida Therapeutics Latest Developments

12 Research Findings and Conclusion

Table 1. B Cell Maturation Antigen Targeted Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Antibody-Drug Conjugates

Table 3. Major Players of CAR-T Cells and Bispecific T Cell Engagers

Table 4. B Cell Maturation Antigen Targeted Therapy Market Size CAGR by Treatment Method (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global B Cell Maturation Antigen Targeted Therapy Market Size by Treatment Method (2017-2022) & ($ Millions)

Table 6. Global B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Treatment Method (2017-2022)

Table 7. B Cell Maturation Antigen Targeted Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global B Cell Maturation Antigen Targeted Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Application (2017-2022)

Table 10. Global B Cell Maturation Antigen Targeted Therapy Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share by Player (2020-2022)

Table 12. B Cell Maturation Antigen Targeted Therapy Key Players Head office and Products Offered

Table 13. B Cell Maturation Antigen Targeted Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global B Cell Maturation Antigen Targeted Therapy Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Regions (2017-2022)

Table 18. Americas B Cell Maturation Antigen Targeted Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Country (2017-2022)

Table 20. Americas B Cell Maturation Antigen Targeted Therapy Market Size by Treatment Method (2017-2022) & ($ Millions)

Table 21. Americas B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Treatment Method (2017-2022)

Table 22. Americas B Cell Maturation Antigen Targeted Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Application (2017-2022)

Table 24. APAC B Cell Maturation Antigen Targeted Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Region (2017-2022)

Table 26. APAC B Cell Maturation Antigen Targeted Therapy Market Size by Treatment Method (2017-2022) & ($ Millions)

Table 27. APAC B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Treatment Method (2017-2022)

Table 28. APAC B Cell Maturation Antigen Targeted Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Application (2017-2022)

Table 30. Europe B Cell Maturation Antigen Targeted Therapy Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Country (2017-2022)

Table 32. Europe B Cell Maturation Antigen Targeted Therapy Market Size by Treatment Method (2017-2022) & ($ Millions)

Table 33. Europe B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Treatment Method (2017-2022)

Table 34. Europe B Cell Maturation Antigen Targeted Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size by Treatment Method (2017-2022) & ($ Millions)

Table 39. Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Treatment Method (2017-2022)

Table 40. Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of B Cell Maturation Antigen Targeted Therapy

Table 43. Key Market Challenges & Risks of B Cell Maturation Antigen Targeted Therapy

Table 44. Key Industry Trends of B Cell Maturation Antigen Targeted Therapy

Table 45. Global B Cell Maturation Antigen Targeted Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global B Cell Maturation Antigen Targeted Therapy Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global B Cell Maturation Antigen Targeted Therapy Market Size Forecast by Treatment Method (2023-2028) & ($ Millions)

Table 48. Global B Cell Maturation Antigen Targeted Therapy Market Size Market Share Forecast by Treatment Method (2023-2028)

Table 49. Global B Cell Maturation Antigen Targeted Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global B Cell Maturation Antigen Targeted Therapy Market Size Market Share Forecast by Application (2023-2028)

Table 51. GlaxoSmithKline Details, Company Type, B Cell Maturation Antigen Targeted Therapy Area Served and Its Competitors

Table 52. GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Product Offered

Table 53. GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. GlaxoSmithKline Main Business

Table 55. GlaxoSmithKline Latest Developments

Table 56. Johnson & Johnson Details, Company Type, B Cell Maturation Antigen Targeted Therapy Area Served and Its Competitors

Table 57. Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Product Offered

Table 58. Johnson & Johnson Main Business

Table 59. Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Johnson & Johnson Latest Developments

Table 61. Amgen Details, Company Type, B Cell Maturation Antigen Targeted Therapy Area Served and Its Competitors

Table 62. Amgen B Cell Maturation Antigen Targeted Therapy Product Offered

Table 63. Amgen Main Business

Table 64. Amgen B Cell Maturation Antigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Amgen Latest Developments

Table 66. Seagen Details, Company Type, B Cell Maturation Antigen Targeted Therapy Area Served and Its Competitors

Table 67. Seagen B Cell Maturation Antigen Targeted Therapy Product Offered

Table 68. Seagen Main Business

Table 69. Seagen B Cell Maturation Antigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. Seagen Latest Developments

Table 71. AbbVie Details, Company Type, B Cell Maturation Antigen Targeted Therapy Area Served and Its Competitors

Table 72. AbbVie B Cell Maturation Antigen Targeted Therapy Product Offered

Table 73. AbbVie Main Business

Table 74. AbbVie B Cell Maturation Antigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. AbbVie Latest Developments

Table 76. Novartis Details, Company Type, B Cell Maturation Antigen Targeted Therapy Area Served and Its Competitors

Table 77. Novartis B Cell Maturation Antigen Targeted Therapy Product Offered

Table 78. Novartis Main Business

Table 79. Novartis B Cell Maturation Antigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Novartis Latest Developments

Table 81. BioTherapeutics Details, Company Type, B Cell Maturation Antigen Targeted Therapy Area Served and Its Competitors

Table 82. BioTherapeutics B Cell Maturation Antigen Targeted Therapy Product Offered

Table 83. BioTherapeutics Main Business

Table 84. BioTherapeutics B Cell Maturation Antigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. BioTherapeutics Latest Developments

Table 86. Celgene Details, Company Type, B Cell Maturation Antigen Targeted Therapy Area Served and Its Competitors

Table 87. Celgene B Cell Maturation Antigen Targeted Therapy Product Offered

Table 88. Celgene Main Business

Table 89. Celgene B Cell Maturation Antigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Celgene Latest Developments

Table 91. Bluebird Bio Details, Company Type, B Cell Maturation Antigen Targeted Therapy Area Served and Its Competitors

Table 92. Bluebird Bio B Cell Maturation Antigen Targeted Therapy Product Offered

Table 93. Bluebird Bio Main Business

Table 94. Bluebird Bio B Cell Maturation Antigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Bluebird Bio Latest Developments

Table 96. Bristol Mayer Squibb Details, Company Type, B Cell Maturation Antigen Targeted Therapy Area Served and Its Competitors

Table 97. Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Product Offered

Table 98. Bristol Mayer Squibb Main Business

Table 99. Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. Bristol Mayer Squibb Latest Developments

Table 101. Carsgen Therapeutics Details, Company Type, B Cell Maturation Antigen Targeted Therapy Area Served and Its Competitors

Table 102. Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offered

Table 103. Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Carsgen Therapeutics Main Business

Table 105. Carsgen Therapeutics Latest Developments

Table 106. Juno Therapeutics Details, Company Type, B Cell Maturation Antigen Targeted Therapy Area Served and Its Competitors

Table 107. Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offered

Table 108. Juno Therapeutics Main Business

Table 109. Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. Juno Therapeutics Latest Developments

Table 111. Cogent Bioscience Details, Company Type, B Cell Maturation Antigen Targeted Therapy Area Served and Its Competitors

Table 112. Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Product Offered

Table 113. Cogent Bioscience Main Business

Table 114. Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. Cogent Bioscience Latest Developments

Table 116. CRISPR Therapeutics Details, Company Type, B Cell Maturation Antigen Targeted Therapy Area Served and Its Competitors

Table 117. CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offered

Table 118. CRISPR Therapeutics Main Business

Table 119. CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. CRISPR Therapeutics Latest Developments

Table 121. Allogene Therapeutics Details, Company Type, B Cell Maturation Antigen Targeted Therapy Area Served and Its Competitors

Table 122. Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offered

Table 123. Allogene Therapeutics Main Business

Table 124. Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 125. Allogene Therapeutics Latest Developments

Table 126. Harpoon Therapeutics Details, Company Type, B Cell Maturation Antigen Targeted Therapy Area Served and Its Competitors

Table 127. Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offered

Table 128. Harpoon Therapeutics Main Business

Table 129. Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 130. Harpoon Therapeutics Latest Developments

Table 131. Poseida Therapeutics Details, Company Type, B Cell Maturation Antigen Targeted Therapy Area Served and Its Competitors

Table 132. Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Product Offered

Table 133. Poseida Therapeutics Main Business

Table 134. Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 135. Poseida Therapeutics Latest Developments

List of Figures

Figure 1. B Cell Maturation Antigen Targeted Therapy Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global B Cell Maturation Antigen Targeted Therapy Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Treatment Method in 2021

Figure 7. B Cell Maturation Antigen Targeted Therapy in Hospitals

Figure 8. Global B Cell Maturation Antigen Targeted Therapy Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. B Cell Maturation Antigen Targeted Therapy in Clinics

Figure 10. Global B Cell Maturation Antigen Targeted Therapy Market: Clinics (2017-2022) & ($ Millions)

Figure 11. B Cell Maturation Antigen Targeted Therapy in Others

Figure 12. Global B Cell Maturation Antigen Targeted Therapy Market: Others (2017-2022) & ($ Millions)

Figure 13. Global B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Application in 2021

Figure 14. Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share by Player in 2021

Figure 15. Global B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Regions (2017-2022)

Figure 16. Americas B Cell Maturation Antigen Targeted Therapy Market Size 2017-2022 ($ Millions)

Figure 17. APAC B Cell Maturation Antigen Targeted Therapy Market Size 2017-2022 ($ Millions)

Figure 18. Europe B Cell Maturation Antigen Targeted Therapy Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size 2017-2022 ($ Millions)

Figure 20. Americas B Cell Maturation Antigen Targeted Therapy Value Market Share by Country in 2021

Figure 21. Americas B Cell Maturation Antigen Targeted Therapy Consumption Market Share by Treatment Method in 2021

Figure 22. Americas B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Application in 2021

Figure 23. United States B Cell Maturation Antigen Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada B Cell Maturation Antigen Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico B Cell Maturation Antigen Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil B Cell Maturation Antigen Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Region in 2021

Figure 28. APAC B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Application in 2021

Figure 29. China B Cell Maturation Antigen Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan B Cell Maturation Antigen Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea B Cell Maturation Antigen Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia B Cell Maturation Antigen Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 33. India B Cell Maturation Antigen Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia B Cell Maturation Antigen Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Country in 2021

Figure 36. Europe B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Treatment Method in 2021

Figure 37. Europe B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Application in 2021

Figure 38. Germany B Cell Maturation Antigen Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 39. France B Cell Maturation Antigen Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK B Cell Maturation Antigen Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy B Cell Maturation Antigen Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia B Cell Maturation Antigen Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Treatment Method in 2021

Figure 45. Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size Market Share by Application in 2021

Figure 46. Egypt B Cell Maturation Antigen Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa B Cell Maturation Antigen Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel B Cell Maturation Antigen Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey B Cell Maturation Antigen Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country B Cell Maturation Antigen Targeted Therapy Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 52. APAC B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 53. Europe B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 55. United States B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 56. Canada B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 57. Mexico B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 58. Brazil B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 59. China B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 60. Japan B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 61. Korea B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 63. India B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 64. Australia B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 65. Germany B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 66. France B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 67. UK B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 68. Italy B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 69. Russia B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 70. Spain B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 71. Egypt B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 72. South Africa B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 73. Israel B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 74. Turkey B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries B Cell Maturation Antigen Targeted Therapy Market Size 2023-2028 ($ Millions)